Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Pharmacogenetics of Anti-Diabetes Drugs.

Distefano JK, Watanabe RM.

Pharmaceuticals (Basel). 2010 Aug 1;3(8):2610-2646.

2.

Pharmacogenetics of metformin response: a step in the path toward personalized medicine.

Reitman ML, Schadt EE.

J Clin Invest. 2007 May;117(5):1226-9. Review.

3.

Drug Metabolizing Enzymes in Type II Diabetes and their Pharmacogenetics During Therapy of Anti-Diabetes Drugs.

Chakraborty C, Hsu MJ, Agoramoorthy G.

Curr Drug Metab. 2015;16(10):864-76. Review.

PMID:
26652255
4.

Pharmacogenetic studies update in type 2 diabetes mellitus.

Singh S, Usman K, Banerjee M.

World J Diabetes. 2016 Aug 10;7(15):302-15. doi: 10.4239/wjd.v7.i15.302. Review.

5.

Treatment of type 2 diabetes mellitus: pharmacologic intervention.

McCormick M, Quinn L.

J Cardiovasc Nurs. 2002 Jan;16(2):55-67. Review.

PMID:
11800068
6.

History of current non-insulin medications for diabetes mellitus.

Quianzon CC, Cheikh IE.

J Community Hosp Intern Med Perspect. 2012 Oct 15;2(3). doi: 10.3402/jchimp.v2i3.19081. Print 2012.

7.

Advances in the treatment of type 2 diabetes mellitus.

Israili ZH.

Am J Ther. 2011 Mar-Apr;18(2):117-52. doi: 10.1097/MJT.0b013e3181afbf51. Review.

PMID:
19834322
8.

The entero-insular axis: implications for human metabolism.

Ranganath LR.

Clin Chem Lab Med. 2008;46(1):43-56. Review.

PMID:
18020966
9.

Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.

Staiger H, Schaeffeler E, Schwab M, Häring HU.

Rev Diabet Stud. 2015 Fall-Winter;12(3-4):363-76. doi: 10.1900/RDS.2015.12.363. Epub 2016 Feb 10.

10.

A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease.

Fisman EZ, Tenenbaum A.

Cardiovasc Diabetol. 2009 Jul 20;8:38. doi: 10.1186/1475-2840-8-38. Review.

11.

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.

Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS.

Endocr Pract. 2009 Sep-Oct;15(6):540-59. Erratum in: Endocr Pract. 2009 Nov-Dec;15(7):768-70.

PMID:
19858063
12.

The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.

Munir KM, Davis SN.

Expert Opin Pharmacother. 2015;16(15):2331-41. doi: 10.1517/14656566.2015.1084502. Epub 2015 Sep 4. Review.

PMID:
26340427
13.

More choices than ever before: emerging therapies for type 2 diabetes.

Campbell RK, White JR Jr.

Diabetes Educ. 2008 May-Jun;34(3):518-34. doi: 10.1177/0145721708317870.

PMID:
18535325
14.

Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?

Emami-Riedmaier A, Schaeffeler E, Nies AT, Mörike K, Schwab M.

J Intern Med. 2015 Feb;277(2):235-47. doi: 10.1111/joim.12330. Review.

15.

beta-cell failure in diabetes and preservation by clinical treatment.

Wajchenberg BL.

Endocr Rev. 2007 Apr;28(2):187-218. Epub 2007 Mar 12. Review.

PMID:
17353295
16.

Noninsulin pharmacological management of type 1 diabetes mellitus.

Garg V.

Indian J Endocrinol Metab. 2011 Jul;15(Suppl 1):S5-S11. doi: 10.4103/2230-8210.83053.

17.

Dipeptidyl peptidase IV inhibitors: a new paradigm in type 2 diabetes treatment.

Janardhan S, Sastry GN.

Curr Drug Targets. 2014 Jun;15(6):600-21. Review.

PMID:
24611684
18.

AHRQ's comparative effectiveness research on oral medications for type 2 diabetes: a summary of the key findings.

Bennett WL, Balfe LM, Faysal JM.

J Manag Care Pharm. 2012 Jan-Feb;18(1 Suppl A):1-22. Review.

19.

Pathophysiology of diabetes in elderly people.

Paolisso G.

Acta Biomed. 2010;81 Suppl 1:47-53. Review.

PMID:
20518191
20.

Genetic polymorphisms in diabetes: influence on therapy with oral antidiabetics.

Glamočlija U, Jevrić-Čaušević A.

Acta Pharm. 2010 Dec;60(4):387-406. doi: 10.2478/v10007-010-0040-9. Review.

PMID:
21169132

Supplemental Content

Support Center